Neurobiology of Disease & Regeneration | Neuronal Signaling Mechanisms | Neuropharmacology & Psychopharmacology | Mood Disorders | Methods for Diagnostic & Therapeutic Studies
CoQ 10 may improve mood and energy conditions in bipolar depressed brain
Chun Zuo*, Brent Forester, Caitlin Ravichandran, Fei Du, Bruce Cohen, Perry Renshaw
*Corresponding author: Chun Zuo
Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, USA
F1000Posters 2012, 3: 588 (poster) [English]
Poster [546.74 KB]
Presented at
67th Society of Biological Psychiatry Annual Meeting 2012,
2 - 4 May 2012, 933
To evaluate if Coenzyme Q 10 (CoQ 10 ) may improve mood and energy conditions in older patients with bipolar depression. Specifically, mood was evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS), and energy conditions were assessed with 31P-magnetic resonance spectroscopy (31P-MRS) to measure the forward rate constant (Kfor) of creatine kinase (CK) enzymatic activity before and after an 8-week treatment with CoQ 10 .
CoQ 10 improved mood condition at week 4 in the 8-week treatment, but its impact on the energy condition needs to be determined with a larger sample size.
To evaluate the CoQ 10 treatment efficacy in a larger group of patients with bipolar depression.
Copyrights:
Figures 4 and 6 were reproduced with kind permission from Forester BP et al (2012) J Geriatr Psychiatry Neurol. 25(1): 43-50
No relevant competing interests disclosed.
National Institutes of Health (NIH), DA015116
NARSAD, K23 077287-¬‐01
Rogers Family Foundation, R21MH081076
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY-NC Creative Commons 3.0 License
